Humanigen Investor Relations Material
Latest events
Q4 2022
30 Mar, 2023
Q4 2021
1 Mar, 2022
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Humanigen Inc
Access all reports
Humanigen Inc is a biopharmaceutical company developing therapies aimed at preventing and treating immune hyper-response conditions. The company’s research focuses on addressing inflammatory and infectious diseases. Humanigen operates within the healthcare and biotechnology sectors. The company is headquartered in Short Hills, New Jersey, and its shares are listed on the NASDAQ.
Latest articles
)
Airbnb: The Hospitality Giant Without Property
Airbnb has grown from an idea to help the Co-Founders make rent, to one of the most dominant companies in the global hospitality industry.
13 Jun 2025
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
Ticker symbol
HGEN
Country
🇺🇸 United States